Health Care

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is to achieve $5.42 Price Target in next 52-weeks

0 60

Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) declined -5.67% and ended at $0.87 smaller than previous closing price of $0.92. The total 3.57 million shares were bought and sold throughout the most recent trading session more than average volume of 645.88 thousand shares.

Tonix Pharmaceuticals Holding Corp. (TNXP):

Currently Tonix Pharmaceuticals Holding Corp. (TNXP) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “2″ Analysts”. “0” rated “Sell” for the company. “1” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.

Analysts are expecting that the company to achieve $5.42 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $10.00 however minimum price target advised by analysts is $1.25. The Median price target for the stock is measured at $5.00.

Presently, Analysts decided consensus EPS estimate of $-0.36 for present quarter and one month ago projected EPS estimate was at $-0.42. If we take a look at back 3 month ago, consensus EPS estimate was $-0.53.

A current consensus EPS estimate for next quarter is at $-0.27 and 3 month ago EPS forecast was $-0.50. Have a look at back 1 month ago, consensus EPS forecast was seen at $-0.34.

For current fiscal year, most recent EPS estimate is set at $-1.77 based on Analyst consensus and three month ago consensus EPS opinions was at $-2.39. During period one month ago, consensus EPS forecast was decided at $-1.95.

A current consensus EPS projection for next fiscal year is observed at $-1.27 and one month ago consensus EPS forecast was at $-1.43. Take a look at back three month ago, consensus EPS estimate opinions was decided at $-1.85 by analysts.

One Month ago, the stock has gained consensus mean rating of Buy based on the analysis of brokerage analyst firms polled. 3 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 0 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.

Three Months Ago, Analysts recommended an average brokerage rating of Buy derived from brokerage firms, according to FactSet. 3 said a “Buy Rating” and 0 announced “Overweight Rating”. 0 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.


About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.